Drug Profile
Nevirapine - Cipla
Alternative Names: NevimuneLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Cipla
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Pyridines; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 29 Nov 2018 Nevirapine is not yet available in USA for HIV-1 infections (Cipla website, November 2018)